Carasent

Carasent ASA - announcement of revised financial targets

Carasent ASA ("Carasent" or the "Company") is currently executing on its plan

to create long-term shareholder value, as explained on the Capital Markets Day

7 November 2023. Due to order inflow being significantly above expectations;

better than anticipated success on cost savings; and continued low churn,

Carasent has improved visibility on the expected growth and profitability

during the coming years. The Company therefore revises the financial targets

as follows.

Financial targets 2024:

* Revenues of NOK 270 million (15% organic growth)

* EBITDA in excess of NOK 40 million

* EBITDA -- capex around NOK 0

* EBITDA -- capex of NOK 20 million excluding Webdoc X

Financial targets 2025:

* Revenues above NOK 320 million (20% organic growth)

* EBITDA of NOK 80 million

* EBITDA -- capex of NOK 40 million

* EBITDA -- capex of NOK 60 million excluding Webdoc X

Carasent is executing its strategy to reach targets with the current company

structure. Potential acquisitions and divestments are not included. The

financial targets are intended for a long-term perspective, and there will be

variations between quarters. The new targets replace the long-term financial

targets announced on 7 November 2023.

Carasent CEO Daniel Öhman comments:

| The strength of a business like ours, with minimal churn, strong growth and

| cost control, is that bottom line scales rapidly as revenues grow. The

| additional customer contracts and cost reductions lead us to believe that it

| is time to update our financial goals.

Note: EBITDA and EBITDA - capex is alternative performance measures as a

supplement to the financial statements prepared in accordance with IFRS.

Please see the latest quarterly report for further details.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 19 no. 3. The information was submitted for publication

at 2024-04-23 16:31 CEST.

AI Terminal